Filter
1
Active & Responsive

MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

for
Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06648434

Phase 1, Recruiting
Active & Responsive

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

for
Intrahepatic Cholangiocarcinoma
Location: Baltimore MD
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Sex: All

Age: 18 - 70+

Code: NCT04078230

Recruiting
Active & Responsive

STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

for
Malignant Neoplasm of Prostate,
Location: Cleveland OH
Sponsor: Angela Y. Jia, MD PhD

Sex: Male

Age: 18+

Code: NCT06574880

Phase 1, Phase 2, Recruiting
Active & Responsive

Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management

for
Breast Cancer Female
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: Female

Age: 65+

Code: NCT07242118

Recruiting
New

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Non-Small Cell Lung Cancer,
Location: Huntersville NC, Grand Rapids MI, Irving TX
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07807956

Phase 1, Recruiting

Interested in new solid tumors trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid Tumors

for
Colorectal Cancer, Advanced/Metastatic Solid Tumor,
Location: Scottsdale AZ
Sponsor: LTZ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07878988

Phase 1, Recruiting
New

Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease

for
Chronic Graft Versus Host Disease,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07733141

Recruiting
New

Ultra-Rapid Profiling and Drug Screening for Treatment Selection in Patients With Relapsed or Recurrent Rare Brain Tumors

for
Rare CNS Tumor, FOXR2-activated, BCOR ITD Sarcoma, CNS Sarcoma,
Location: Washington D.C. DC
Sponsor: Adriana Fonseca

Sex: All

Age: 0 - 45

Code: NCT07851636

Recruiting
New

A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.

for
Ovarian Cancer, Advanced Malignant Solid Tumor
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07389239

Phase 1, Phase 2, Recruiting
New

Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors

for
Chemotherapy-Induced Peripheral Neuropathy,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT07673614

Recruiting
New

Imaging Study of [89Zr]DFO-YS5 for Cancer Detection

for
Bladder Cancer, Nerve Sheath Tumor, Nerve Sheath Tumors,
Location: San Francisco CA
Sponsor: Robert Flavell, MD, PhD

Sex: All

Age: 18+

Code: NCT07664397

Phase 1, Recruiting
New

A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer

for
Cancer, Breast Cancer
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: Female

Age: 20 - 70+

Code: NCT07698314

Recruiting
New

Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors

for
Metastatic Malignant Solid Neoplasm,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 15+

Code: NCT07856394

Recruiting
New

EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer

for
Cancer, Breast Cancer
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: Female

Age: 20 - 70+

Code: NCT07704476

Recruiting
New

An Artificial Intelligence-Powered Supportive Care Chatbot to Address the Supportive Care Needs of Young Adult Cancer Survivors

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18 - 39

Code: NCT07772596

Recruiting

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

for
Brain Metastases, Cancer (With CNS Involvement)
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT07227610

Phase 2, Recruiting

A Study of VET3-TGI in Patients With Solid Tumors

for
Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer,
Location: Miami FL, Pittsburgh PA, Indianapolis IN, Houston TX,
Sponsor: KaliVir Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06444815

Phase 1, Recruiting

64Cu-GRIP B in Patients With Advanced Malignancies

for
Prostate Cancer, Renal Cancer, Urethral Cancer,
Location: San Francisco CA
Sponsor: Rahul Aggarwal

Sex: All

Age: 18+

Code: NCT05888532

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: New York NY, Jacksonville FL, Cleveland OH,
Sponsor: GI Innovation, Inc.

Sex: All

Age: 18+

Code: NCT05824975

Phase 1, Phase 2, Recruiting

Circulating Tumor DNA Exposure in Peripheral Blood

for
Colorectal Cancer, Pancreatic Adenocarcinoma, Gastric Cancer,
Location: Orlando FL, Celebration FL, Centerville OH, Dayton OH
Sponsor: Quantgene Inc.

Sex: All

Age: 18+

Code: NCT03517332

Recruiting